Juszczak, Edmund

Donepezil and memantine for moderate-to-severe Alzheimer's disease

Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 782

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Domingo, P., Mur, I., Mateo, G. M., Gutierrez, M. D. M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., et al. (2021) · JAMA

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 678

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial

Ballard, C., Hanney, M. L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., Gill, R., Juszczak, E., Yu, L.-M., & Jacoby, R. (2009) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 567

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

Gamble, C., Krishan, A., Stocken, D., Lewis, S., Juszczak, E., Doré, C., Williamson, P. R., Altman, D. G., Montgomery, A., Lim, P., et al. (2017) · JAMA

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 536

Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial

Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., & Millar, M. R. (2016) · The Lancet

Infant Nutrition and HealthProbiotics and Fermented Foods

Cited by 387

Donepezil for the Treatment of Agitation in Alzheimer's Disease

Howard, R. J., Juszczak, E., Ballard, C. G., Bentham, P., Brown, R. G., Bullock, R., Burns, A. S., Holmes, C., Jacoby, R., Johnson, T., et al. (2007) · New England Journal of Medicine

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 327

Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement

Juszczak, E., Altman, D. G., Hopewell, S., & Schulz, K. (2019) · JAMA

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 324

Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial

Eddleston, M., Juszczak, E., Buckley, N. A., Senarathna, L., Mohamed, F., Dissanayake, W., Hittarage, A., Azher, S., Jeganathan, K., Jayamanne, S., et al. (2008) · The Lancet

Poisoning and overdose treatmentsParaquat toxicity studies and treatments

Cited by 227

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial

Azzopardi, D., Robertson, N. J., Bainbridge, A., Cady, E., Charles-Edwards, G., Deierl, A., Fagiolo, G., Franks, N. P., Griffiths, J., Hajnal, J., et al. (2016) · The Lancet Neurology

Neonatal and fetal brain pathologyThermal Regulation in Medicine

Cited by 220

Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: A mixed-methods study

Karim, J. N., Campbell, H., Pandya, P., Wilson, E. C. F., Alfirevic, Z., Chudleigh, T., Duff, E., Fisher, J., Goodman, H., Hinton, L., et al. (2025) · Health Technology Assessment

Prenatal Screening and DiagnosticsCongenital Anomalies and Fetal Surgery

Cited by 5